PL3845524T3 - Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania - Google Patents
Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowaniaInfo
- Publication number
- PL3845524T3 PL3845524T3 PL19772121.0T PL19772121T PL3845524T3 PL 3845524 T3 PL3845524 T3 PL 3845524T3 PL 19772121 T PL19772121 T PL 19772121T PL 3845524 T3 PL3845524 T3 PL 3845524T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- application
- benzoic acid
- acid compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/307—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810225467 | 2018-03-19 | ||
| PCT/CN2019/078059 WO2019179346A1 (zh) | 2018-03-19 | 2019-03-14 | 苯甲酸类化合物及其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3845524T3 true PL3845524T3 (pl) | 2022-10-24 |
Family
ID=66487918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19772121.0T PL3845524T3 (pl) | 2018-03-19 | 2019-03-14 | Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11578049B2 (pl) |
| EP (1) | EP3845524B1 (pl) |
| CN (1) | CN109776466B (pl) |
| ES (1) | ES2927538T3 (pl) |
| PL (1) | PL3845524T3 (pl) |
| PT (1) | PT3845524T (pl) |
| WO (1) | WO2019179346A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112794831B (zh) * | 2021-04-06 | 2021-07-27 | 北京理工大学 | 3-(3′-羟基丁基)异苯并呋喃-1(3h)-酮衍生物及其组合物、制备方法和用途 |
| CN117159531B (zh) * | 2023-07-28 | 2026-02-03 | 平原实验室 | 布罗佐喷钠在制备防治老年性痴呆药物中的应用 |
| CN118978500A (zh) * | 2024-08-02 | 2024-11-19 | 苏州摩笛尔科技有限公司 | 一种靶向含氟丁苯酞、合成方法及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1182127C (zh) * | 2000-06-28 | 2004-12-29 | 中国医学科学院药物研究所 | 新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物 |
| CN1243541C (zh) * | 2002-05-09 | 2006-03-01 | 中国医学科学院药物研究所 | 2-(α-羟基戊基)苯甲酸盐及其制法和用途 |
| CN100540523C (zh) * | 2004-06-17 | 2009-09-16 | 北京天衡药物研究院 | L-2-(α-羟基戊基)苯甲酸盐及其制法和用途 |
| CN101054346A (zh) * | 2006-04-13 | 2007-10-17 | 温建波 | 一组新化合物及其组合物的制备方法和用途 |
| CN100554259C (zh) * | 2007-04-12 | 2009-10-28 | 郑州大学 | 2-苯并[c]呋喃酮化合物及其应用 |
| CN101337955B (zh) * | 2008-08-13 | 2012-05-09 | 石药集团中奇制药技术(石家庄)有限公司 | 一种制备高光学纯度3-取代手性苯酞类化合物的方法 |
| CN101402565B (zh) * | 2008-11-14 | 2012-07-04 | 郑州大学 | 卤代2-(a-羟基戊基)苯甲酸盐及其制法和用途 |
| CN102397272B (zh) * | 2010-09-17 | 2013-08-14 | 石药集团恩必普药业有限公司 | 丁基苯酞及其衍生物在制备预防和治疗als的药物中的应用 |
| WO2013102935A2 (en) * | 2012-01-03 | 2013-07-11 | Council Of Scientific & Industrial Research | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES |
| CN104086399B (zh) * | 2013-07-17 | 2016-08-24 | 浙江奥翔药业股份有限公司 | 5-溴-2-(α-羟基戊基)苯甲酸钠盐的不同晶型及其制备方法 |
-
2019
- 2019-03-14 PT PT197721210T patent/PT3845524T/pt unknown
- 2019-03-14 ES ES19772121T patent/ES2927538T3/es active Active
- 2019-03-14 EP EP19772121.0A patent/EP3845524B1/en active Active
- 2019-03-14 WO PCT/CN2019/078059 patent/WO2019179346A1/zh not_active Ceased
- 2019-03-14 CN CN201910191840.3A patent/CN109776466B/zh active Active
- 2019-03-14 PL PL19772121.0T patent/PL3845524T3/pl unknown
-
2020
- 2020-09-21 US US17/026,339 patent/US11578049B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3845524A1 (en) | 2021-07-07 |
| CN109776466A (zh) | 2019-05-21 |
| EP3845524B1 (en) | 2022-08-31 |
| CN109776466B (zh) | 2023-01-31 |
| WO2019179346A1 (zh) | 2019-09-26 |
| ES2927538T3 (es) | 2022-11-08 |
| EP3845524A4 (en) | 2021-07-21 |
| US20210002244A1 (en) | 2021-01-07 |
| PT3845524T (pt) | 2022-09-28 |
| US11578049B2 (en) | 2023-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285178A (en) | Compounds and uses thereof | |
| HUE058687T2 (hu) | Azonnali elõkészítés | |
| PL3838888T3 (pl) | Triestry kwasu cykloheksanotripropionowego | |
| PL3761980T3 (pl) | Związki aminokwasowe i sposoby zastosowania | |
| IL282998A (en) | Pyridazinone compounds and uses thereof | |
| PT3259253T (pt) | Sulfonilureias e compostos relacionados e uso dos mesmos | |
| EP3473614A4 (en) | SULFONIC ACID ESTER COMPOUND AND USE THEREOF | |
| IL278122B1 (en) | Pteridinone compounds and uses thereof | |
| EP3473613A4 (en) | SULFONIC ACID ESTER COMPOUND AND USE THEREOF | |
| EP3250367A4 (en) | ACTIVE CALIBRATION | |
| EP3808783A4 (en) | Novel crosslinked alginic acid | |
| DK3484457T3 (da) | Topisk formulering til fremme af sårheling | |
| PL3261437T3 (pl) | Grzybobójcze związki i kompozycje | |
| IL284514A (en) | Halo-allylamine compounds and use thereof | |
| IL285118A (en) | Compounds and uses thereof | |
| EP3600279A4 (en) | 1-amino-1-cyclopropanecaboxylic acid formulations | |
| EP3830103C0 (en) | FLUORINATED BILE ACID DERIVATIVES | |
| IL280533A (en) | Topical composition | |
| EP3600280A4 (en) | 1-AMINO-1-CYCLOPROPANECARBOXYL ACID HYDROCHLORIDE FORMULATIONS | |
| PL3986419T3 (pl) | Pochodne kwasu boronowego i ich zastosowania terapeutyczne | |
| PL3452441T3 (pl) | Pochodne kwasu alfa-truksylowego i ich kompozycje farmaceutyczne | |
| IL282157A (en) | Compounds and therapeutic uses thereof | |
| IL264445A (en) | Compounds and compositions and uses thereof | |
| PL3845524T3 (pl) | Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania | |
| IL287560A (en) | Mrna formulation |